Myeloproliferative Neoplasms Treatment

Service Summary

Myeloproliferative neoplasms (MPNs) are a group of chronic blood cancers characterized by the overproduction of one or more types of blood cells in the bone marrow. This can lead to various complications including an increased risk of blood clots, bleeding, and progression to more aggressive forms of leukemia. Management of MPNs focuses on controlling symptoms, preventing complications, and improving quality of life, often through medications that reduce cell counts, manage symptoms like fatigue and itching, or address specific genetic mutations, with some patients potentially benefiting from stem cell transplantation in select cases.